Rituximab Works for Older Mantle Cell Patients MedPage Today The long-term prognosis for older patients with mantle cell lymphoma is poor. This study evaluated the results of patients 60 years of age or older with mantle cell lymphoma, randomly assigned to R-CHOP therapy followed by maintenance therapy with ... Rituximab Maintenance Effective in Elderly Mantle-Cell Lymphoma Patients R-CHOP Benefits Older Mantle-Cell Lymphoma Patients |
